Zepp Health (ZEPP) Stock Price
Zepp Health Price
Revenue has compounded at 7.0% per year over the past 10 years to 1.82 B USD. Earnings per share have grown at 4.1% per year over the last 5 years. Zepp Health's net margin stands at -15.5%, down from 2.2% several years earlier.
Zepp Health stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Zepp Health business model & stock analysis
Frequently asked questions about Zepp Health
7 analysts currently rate the Zepp Health stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Zepp Health share trades at 2.53 EUR (2.78 USD).
The expected revenue of Zepp Health is 2.26 B USD. This figure is based on current financial data and reflects the company's business performance.
The profit cannot currently be calculated for Zepp Health.
The P/E ratio cannot be calculated for Zepp Health at the moment.
The price-to-sales ratio (P/S) of Zepp Health is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Zepp Health stock.
The Eulerpool Quality Score for Zepp Health is 4/10.
The ISIN of Zepp Health is US98945L2043. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Zepp Health is ZEPP. The ticker symbol is used to trade Zepp Health shares on the stock exchange.
Zepp Health stock
Zepp Health Peer Group
All fundamentals and in-depth analysis of Zepp Health
Our stock analysis for Zepp Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zepp Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.